IR & Media

Ascelia is an oncology-dedicated drug development company located in Malmö, Sweden, focused on the development of novel drugs to improve the life expectancy and quality of life for people living with cancer.

Information to investors and media is presented in the sub-menus.

 

Press Releases & News

Major shareholders

Subscribe to our pressreleases